Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis - 25/06/19
Abstract |
Background |
We aimed to analyse the association between high-level growth-differentiation factor-15 (GDF-15) and mortality, recurrent MI and heart failure compared to low-level GDF-15 in patients with acute coronary syndrome (ACS).
Methods |
PubMed and EMBASE were searched from their commencement to December 2017 for qualified studies that evaluated the associations between GDF-15 and ACS. Risk ratios were synthesized with random effect meta-analysis. Publication bias and sensitivity analyses were also conducted.
Results |
A total of thirteen studies and 43,547 participants were analyzed systematically in our meta-analysis. Our study showed a significant association between GDF-15 values and mortality (p = 0.000, RR = 6.75, 95% CI = 5.81–7.84) and recurrent MI (p = 0.000, RR = 1.95, 95% CI = 1.72–2.21) in the overall analyses. Subgroup analyses revealed similar results. However, there was evidence of heterogeneity in the study of heart failure, whose overall RR was 6.66, with an I2 of 87.3%.
Conclusion |
There was a significant association between high-level GDF-15 and mortality, recurrent MI in patients with ACS. We need more data to research the risk stratification of heart failure in ACS patients in the future.
Le texte complet de cet article est disponible en PDF.Abbreviations : GDF-15, ACS, NSTEMI, STEMI, NT-proBNP, CRP, cTnI, CK-MB, RR, CIs, OR, NOS, AR, CAD, CVD, PI3K, F, M, R, Q
Keywords : STEMI, Unstable angina, Acute coronary syndrome, Growth-differentiation factor-15, Meta-analysis
Plan
| ☆ | No funding. |
Vol 37 - N° 7
P. 1346-1352 - juillet 2019 Retour au numéro
Article précédent
- Initial evaluation and management of wide-complex tachycardia: A simplified and practical approach
- Laszlo Littmann, Elizabeth G. Olson, Michael A. Gibbs
- The controversial role of corticosteroids in septic shock
- Ali Pourmand, Tess Whiteside, David Yamane, Amir Rashed, Maryann Mazer-Amirshahi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?